| Filed | Form | Items | Signal | Score | Summary | Link |
|---|---|---|---|---|---|---|
| 2026-06-09 17:04 | 8-K | ["8.01"] | other | 0.05 | Routine receipt of final holdback payment from prior asset sale to AstraZeneca; no M&A signal. | SEC · detail |
| 2026-05-11 16:05 | 8-K | ["2.02", "9.01"] | other | 0.05 | Routine earnings announcement filing with no M&A-related content or indicators. | SEC · detail |